Equity Overview
Price & Market Data
Price: $14.72
Daily Change: -$0.62 / 4.21%
Daily Range: $14.46 - $15.42
Market Cap: $990,271,872
Daily Volume: 169,768
Performance Metrics
1 Week: -2.00%
1 Month: -9.08%
3 Months: -11.80%
6 Months: -40.07%
1 Year: 5.14%
YTD: -15.45%
Company Details
Employees: 75
Sector: Health technology
Industry: Medical specialties
Country:
Details
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; CellFX nsPFA Percutaneous Electrode system for soft tissue ablation in surgical setting; CellFX nsPFA Cardiac Clamp designed for use in surgical treatment of atrial fibrillation (AF); CellFX nsPFA 360° Cardiac Catheter designed to provide a circumferential, or circular, ablation in a single treatment cycle; and The CellFX Consol, a tunable, software-enabled, and console-based platform designed to accommodate the clinical workflow preferred by physicians. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Miami, Florida.